Dr. Gaudiani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 South Eliseo Dr
Ste 201
Greenbrae, CA 94904Phone+1 415-461-1780Fax+1 415-461-7378
Summary
- Dr. Linda Gaudiani is an endocrinologist in Greenbrae, CA and is affiliated with multiple hospitals in the area, including MarinHealth Medical Center and MarinHealth Medical Center. She received her medical degree from Boston University School of Medicine and has been in practice 41 years. She specializes in diabetes and lipid metabolism and is experienced in diabetes, neuropathy, and obesity. She has more than 10 publications and over 450 citings.
Education & Training
- University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1977 - 1978
- Boston University School of MedicineClass of 1976
- Bryn MawrB.A., English Literature, Cum Laude, 1968 - 1972
- Bryn Mawr CollegeB.A., English Literature, Magna Cum Laude, 1968 - 1972
Certifications & Licensure
- CA State Medical License 1977 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Alpha Omega Alpha Honor Medical Society University of California, San Francisco, 2008
- Volunteer Clinical Faculty Teaching Award, Department of Medicine University of California, San Francisco, 2008
- Join now to see all
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 16 citationsA new look at brittle diabetes.Irl B. Hirsch, Linda M. Gaudiani
Journal of Diabetes and Its Complications. 2021-01-01 - 25 citationsCulinary Medicine: Advancing a Framework for Healthier Eating to Improve Chronic Disease Management and Prevention.B Hirsch Irl, Alison B. Evert, Alexander Fleming, Linda M. Gaudiani, Karl J. Guggenmos
Clinical Therapeutics. 2019-09-20 - 50 citationsEfficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patients.Linda M. Gaudiani, Andrew J. Lewin, Luigi F. Meneghini, Inna Perevozskaya, D. Plotkin
Diabetes, Obesity & Metabolism. 2005-01-01
Journal Articles
- Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020Irl B Hirsch, Linda M Gaudiani, JAMA
- Hemagglutinin receptor binding avidity drives influenza a virus antigenic driftHensley, S.E., Das, S.R., Bailey, A.L, Schmidt, L.M., Hickman, H.D., Jayaraman, A., Viswanathan, K., Raman, R., Sasisekharan, R., Bennink, J.R., Yewdell, J.W., Science, 1/1/2009
- Quantitating presentation of MHC class I-restricted determinantsChen, W., Bennink, J.R., Yewdell, J.W., Meth Mol Biology, 1/1/2001
- Join now to see all
Books/Book Chapters
Authored Content
- Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020May 2020
Press Mentions
- Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes AssociationJune 15th, 2024
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: